News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

BioSpace News - All
There Are Hints That Depomed (DEPO)’s Boss’s Days Are Numbered 2/20/2017
Norwegian Biotech Upstart Has Become a Potential Takeover Target 2/20/2017
This Drug Could Rattle Biogen (BIIB) and Be the Next Billion-Dollar Blockbuster for Celgene (CELG) 2/20/2017
Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics 2/20/2017
Meet the Professor Who Was the First to Question Theranos' Research 2/20/2017
The 10 Biggest Losers in Biopharma Last Year 2/20/2017
SAGE Therapeutics (SAGE) Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity 2/17/2017
Bay Area Biotech Surrozen Launches With $33 Million and Could Double Its Headcount by Next Year 2/17/2017
New SoCal Biotech Jecure Therapeutics Makes Debut and Will Take on NASH 2/17/2017
How Much Money Embattled Theranos Has Left in the Bank 2/17/2017
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos 2/17/2017
Swiss Biotech Santhera (SANN.SW) Opens Up 20 Employee Shop in Massachusetts, Has Plans to Grow 2/17/2017
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa 2/17/2017
5 Best U.S. Regions for Life Science Jobs 2/17/2017
4 Biopharma Stocks a Billionaire Investor Just Bought 2/17/2017
Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech 2/17/2017
3 Biotechs With the Biggest and Most Promising Pipelines 2/17/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial 2/17/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt 2/17/2017
A Look at Whether AbbVie (ABBV) Could Eventually Face the Same Issues as Gilead (GILD) 2/17/2017
Bristol-Myers Squibb (BMY) May Be on the Market, But Pfizer (PFE) Probably Won't Bite 2/16/2017
How to Write the Best Cover Letter for a Research Scientist Job 2/16/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients 2/16/2017
Questions Remain Over Suicide Death of Genentech (RHHBY) Lobbyist 2/16/2017
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY) 2/16/2017
With Ex-Juno (JUNO) Employees on Its Roster, Seattle's Silverback Therapeutics Files $10 Million Out of $60 Million Goal 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
Why Secretive $5 Billion Biotech Moderna May Not be Able to Commercialize Products Into Clinical Trials 2/16/2017
First Ariad (ARIA), Now Senator Bernie Sanders Puts This Drug Company on Notice 2/16/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study 2/16/2017
Bay Area Biotech Ardelyx (ARDX) Rejoices as Lead Drug Hits Phase III Goals 2/16/2017
Ipsen (IPN.PA) Agrees to Hire 100 Merrimack (MACK) Employees Under $575 Million Cancer Deal 2/15/2017
Deal Spree Continues as Allergan (AGN) Inks $2.47 Billion Deal for This Bay Area Biotech 2/15/2017
All Signs Have Gilead (GILD) Gearing Up for a Much-Needed Acquisition 2/15/2017
Former Celgene (CELG) and Medtronic (MDT) CEOs Just Acquired This Maryland Biotech 2/15/2017
Pfizer (PFE) Quietly Takes 16.4% Stake in This SoCal Medtech Firm 2/15/2017
Connecticut's Growing Biopharma Industry Looks to Fill High-Demand Jobs 2/15/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business 2/15/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force 2/15/2017
Why 2017 Could be a Transition Year for Booming Seattle Genetics (SGEN) 2/14/2017
Struggling Teva (TEVA) Mulls Over Sale, Spinoff of Branded Generics Biz 2/14/2017
Eli Lilly (LLY) Quells Rumors Regarding Multi-Million Irish Expansion Plan 2/14/2017
Oops, They Did it Again: Theranos Failed to Inform Patients of Potentially Botched Diabetes Test 2/14/2017
This is How 47 Scientists Were Selected for the Chan-Zuckerberg Biohub 2/13/2017
Why Immunomedics (IMMU)' $2 Billion Deal With Seattle Genetics (SGEN) Has venBio Ticked Off and Red-Faced 2/13/2017
Array BioPharma (ARRY) Has a Potential Blockbuster Melanoma Drug On Its Hands 2/13/2017
Daiichi Sankyo Shutters Yet Another R&D Facility 2/13/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal 2/13/2017
Sarepta (SRPT) Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD 2/13/2017
Why Intercept Pharma (ICPT) Stock Jumped Nearly 10% On Friday After Providing Phase III Update 2/13/2017
Tom Price Confirmed as Donald Trump's Health Chief, But Stock Deals Still Raise Questions 2/10/2017
How Gilead (GILD) Just Lost $9 Billion in Market Value This Week 2/10/2017
Acorda (ACOR) Rockets After Parkinson's Drug Hits Late-Stage Goals 2/10/2017
Massachusetts' Tesaro (TSRO) Being Wooed by Multiple Suitors 2/10/2017
Aurobindo (AUROPHARMA.BO) Eyes U.S. Plant in New Jersey As Trump Calls for Local Drug Production 2/10/2017
New Alewife Research Center to Attract Spillover Demand From Biotechs Unable to Find Space in Kendall Square 2/10/2017
3 Biotech Stocks Able to Weather an Unstable Trump Administration 2/10/2017
Biotech Director at Cambridge's Merrimack (MACK) Arrested for Insider Trading Scheme 2/10/2017
This 20-Employee Kendall Square Biotech Just Secured a Seat on Elon Musk's Upcoming Space Rocket 2/10/2017
This Could be Biogen (BIIB)'s Next $1 Billion Blockbuster 2/10/2017
I Am Woman, Hear Me Roar: GE Corporation (GE) Vows to Place 20,000 Women in Technical Roles By 2020 2/10/2017
Reunited and It Feels So Good: After the Success of XO1, Serial Biotech Duo Launches SuperX 2/9/2017
Reckitt Benckiser (RB.L) to Lay Off 140 Employees in Missouri 2/9/2017
Pfizer (PFE) to Kiss Its Adelaide Operations Goodbye in 2021, Putting 89 Jobs on the Line 2/9/2017
Roche (RHHBY)/Genentech (RHHBY) to Upsize Biologics Manufacturing While Downsizing Small Molecule Manufacturing 2/9/2017
Sinking Teva (TEVA) Needs a New CEO But May Need to Up Salary 2/9/2017
Out of 700+ Applications, Chan-Zuckerberg Biohub Puts 47 Scientists Under Payroll in Its Quest to Cure All Diseases 2/9/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III 2/8/2017
H. Lundbeck A/S (LUN.CO) Throws in the Towel on Alzheimer's Pill, Giving Leeway to Rival Axovant (AXON) 2/8/2017
Heads Up, Startups: Bayer (BAY) is Bringing Its Grants4Apps Accelerator Program to San Francisco 2/8/2017
FDA to Publicly Disclose Advisory Committee Members' CVs 2/8/2017
LabCorp (LH) Makes $8 Billion+ Proposal to CRO PPD (PPDI) 2/8/2017
4 Biotech Stocks Worthy Enough to be Brokers' Favorites 2/8/2017
Warning: Here's The Heartbreaking Truth About Postdoc Job Salaries in Life Sciences 2/8/2017
Eli Lilly (LLY) Seeks "Voluntary Exits" From 200 Researchers 2/8/2017
Attention Bay Area: Chan-Zuckerberg's BIOHUB is Hiring Lots of Scientists 2/8/2017
Genentech (RHHBY)'s $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire 2/8/2017
Teva (TEVA) CEO Abruptly Steps Down, Ex-Celgene (CELG) Boss Named Chairman of the Board 2/8/2017
Biotech Execs are Hoping Trump Will Pick This Man to Head the FDA 2/7/2017
No Looking Back: Cellectis (CLLS) Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial 2/7/2017
GW Pharma (GWPH) Reports First Quarter 2017 Financial Results And Operational Progress 2/7/2017
5 Highest Paid Biopharma CEOs of 2016 2/7/2017
GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected 2/7/2017
2 Biotech Stocks That Could Be in Trouble if President Trump's Proposals Become Reality 2/7/2017
Merck KGaA (MKGAF.PK) Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials 2/7/2017
GlaxoSmithKline (GSK)'s Incoming CEO Preps for Deals, R&D Decisions on New Drugs 2/7/2017
A Look at the Types of Jobs Amgen (AMGN)'s Promise to Trump Will Bring 2/7/2017
Always a Bridesmaid, Never a Bride: Acadia (ACAD) Moves Higher on Takeover Speculation 2/7/2017
AstraZeneca PLC (AZN) Quietly Kills Some Programs 2/6/2017
This Can Be Patheon (PTHN)'s Fate in Trump's Call for Increased Drug Production 2/6/2017
These 5 Biotechs Are Battling Over the $10 Billion Hemophilia Market 2/6/2017
Cash-Rich Amgen (AMGN) Joins the M&A Hunt for Big and Small Deals 2/6/2017
3 Biotechs Breathing Down Bristol-Myers Squibb (BMY)'s Neck 2/6/2017
31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant (AXON) 2/6/2017
Amgen (AMGN) CEO Tells Trump the Company Plans to Hire 1,600 Employees This Year 2/3/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering 2/3/2017
What Went Down in Trump's Meeting With Biotech Execs From Amgen (AMGN), Celgene (CELG) and Merck & Co. (MRK) 2/3/2017
Pfizer (PFE) Turns to JPMorgan to Explore $2 Billion Sale of Certain Assets 2/3/2017
Explosion of Big Data Jobs: These Biotechs Are Hiring Huge Numbers of Data Scientists 2/3/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall 2/3/2017
Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named 2/2/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs 2/2/2017
Eli Lilly (LLY) Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab 2/2/2017
AstraZeneca PLC (AZN) Investors Nervous as Its Recovery Hinges on the Success of New Meds and Key Drug Data 2/2/2017
5 Highlights From Pfizer (PFE)'s 4th Quarter Conference Call 2/2/2017
Bay Area's Galena Biopharma  (GALE) CEO Steps Down, Effective Immediately 2/2/2017
Vividion Therapeutics Launches With $50 Million and a Celgene (CELG) Alum as Executive Chairman 2/2/2017
2 Pharmas Set to Dominate the Future of Healthcare 2/1/2017
2 New Names Emerge as Possible Buyout Candidates for M&A Hungry Gilead (GILD) 2/1/2017
As Part of Digital Industrial Evolution, GE Corporation (GE) Lays Off an Undisclosed Number of Scientists in New York 2/1/2017
Catabasis (CATB) Plunges on DMD Drug Trial Failure 2/1/2017
Bay Area Biotech Employees May Soon Get a New Perk—Affordable Housing 2/1/2017
Meet This Largely Over-Looked Phase 3 Alzheimer's Company 2/1/2017
The 3 Fastest Growing Drugs for Pfizer (PFE) 2/1/2017
Genentech (RHHBY)'s Oncology Boss Jumps Ship to Helm Bellicum (BLCM) 2/1/2017
Cambridge's Dimension Therapeutics (DMTX) Tanks to a New Low After Revealing Interim Hemophilia B Data 2/1/2017
Bill Gates Talks of Biotech as Top 3 Career Choices 2/1/2017
Roche (RHHBY) Not Looking to Unload Its Diabetes Biz After Rumors it May Exit 2/1/2017
Trump to Have Face-to-Face Meeting With Novartis AG (NVS) CEO, Other Pharma Bosses Today 1/31/2017
Bay Area Biotech CEOs React to Trump's Travel Ban 1/31/2017
6 Biopharma Companies Face Catalysts in February 1/31/2017
How Trump's Immigration Ban is Already Hurting Science 1/31/2017
3 Possible Buyout Targets in Biotech Land 1/31/2017
Bay Area's Calithera Biosciences (CALA) Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte (INCY) 1/31/2017
How Bristol-Myers Squibb (BMY) Went From Potential Mega-Acquirer to Vulnerable Mega-Target 1/31/2017
Why Amazon (AMZN) CEO Dropped Millions Into Bay Area's Unity Biotech 1/30/2017
Meet the 29 Year Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) 1/30/2017
This Pharma Giant Just Revealed 7 Years of Its U.S. Drug Price Increase History 1/30/2017
Launching This Week, A Look at Biogen (BIIB)'s Spinoff Bioverativ (BIVVV) 1/30/2017
How Unlikely Allies President Trump and Rep. Cummings Will Take Down Pharma on Drug Pricing—Together 1/30/2017
FDA Lashes Out at Jazz Pharma (JAZZ) CMO for Continued Regulatory Violations 1/30/2017
These 2 New Drugs Make Celgene (CELG) an Even Bigger Biotech Powerhouse 1/30/2017
Ariad (ARIA) Stays Mum on Layoffs After Takeda (TKPYY)'s $5.2 Billion Takeover 1/30/2017
Novo Nordisk A/S (NVO) Pumps $145 Million in UK Diabetes Research Center, Investment Buys More British Scientists 1/30/2017
Cambridge Biotech Jounce (JNCE) Bounces on the IPO Scene, Raises $102 Million 1/27/2017
Facebook Chief, Chan Charity Buys Artificial Intelligence Startup to Battle Disease 1/27/2017
It's Finally Happening: Johnson & Johnson (JNJ) Pays $30 Billion for Actelion (ALIOF.PK), Will Spin Off R&D Unit With $1 Billion Cash 1/27/2017
Celgene (CELG) Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia 1/27/2017
Incyte (INCY) Who? Why This Biotech Would Give Gilead (GILD) a Bang for Its Buck 1/27/2017
How Trump's Federal Hiring Freeze Impacts Biotech and an Already Short-Staffed FDA 1/27/2017
On a Roll, Seattle Genetics (SGEN) Plans to Hire 200 in 2017 1/26/2017
Investment Firm Pumps $800 Million Into Google (GOOG)'s Verily 1/26/2017
Endo International (ENDP) Eliminates 90 Jobs in Restructuring 1/26/2017
Social Media Rumors of Juno (JUNO) Acquisition Cause Stock Jitters 1/26/2017
Booming Illumina (ILMN) Expands With a Spanking New Building in San Diego, Hiring More Than 100 1/26/2017
Watch Out! Novartis AG (NVS) Hungry for Small Takeover Targets With Early-Stage Drugs 1/26/2017
The Rise and Fall of Cambridge Biotech Startup Gen9 1/26/2017
Why Pfizer (PFE) Could be Johnson & Johnson (JNJ)'s Biggest Headache in 2017 1/25/2017
New Frontrunner Emerges for Top FDA Job 1/25/2017
3 Biotechs Most Likely to be Taken Out in 2017 1/25/2017
Women Scientists Call on President Trump in Open Letter 1/25/2017
4 Biotechs to Make a Move On Now 1/25/2017
Kendall Square Upstart Cue BioPharma Comes Out of Stealth Mode With $26 Million 1/25/2017
Why Celgene (CELG) Should Consider Buying Rival Biogen (BIIB) 1/24/2017
Meet the 25-Year-Old CEO Helming Boston Cancer Startup ConquerX 1/24/2017
What You Need to Know About Homology Medicines 1/24/2017
Trump's Controversial Education Nominee Betsy DeVos Also Linked to Theranos 1/24/2017
Two Former AllCells Employees Allegedly Took Confidential Info to Launch Cepheus Biosciences 1/24/2017
What You Need to Know About Pliant 1/24/2017
Cellceutix (CTIX) CEO Unhinged After Anonymous Short Trader's Attacks 1/23/2017
Success of Pfizer (PFE)’s Humira Biosimilar for Rheumatoid Arthritis in Phase III Bodes Well for Its Strong Biosimilar Pipeline 1/23/2017
Who Might or Might Not Buy Regeneron (REGN), And Why 1/23/2017
What You Need to Know About Fulcrum Therapeutics 1/23/2017
Earnings Preview: Here's a Look at What to Expect From 7 Biopharmas 1/23/2017
PAGXXV Genomic Sequencing: New Machines, New Era for Illumina (ILMN), Pacific Biosciences (PACB) and Oxford Nanopore 1/23/2017
4 Key Strategies on How Pharma Can Successfully Negotiate Drug Prices With President Trump 1/23/2017
NIH Director to Keep Job Under Trump, for Now 1/23/2017
What You Need to Know About Arrivo BioVentures 1/23/2017
485 Eli Lilly (LLY) Employees Will be Out of Work Beginning March 31 1/23/2017
Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech 1/20/2017
What You Need to Know About Oncorus 1/20/2017
Theranos' Last Defender Claims Federal Witch Hunt 1/20/2017
9 Tips to Create the Best Clinical Research Resume or CV 1/20/2017
Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry 1/20/2017
A Peek Behind the Curtain of the Ariad (ARIA)-Takeda (TKPYY) Deal 1/20/2017
GlaxoSmithKline (GSK) Poaches AstraZeneca PLC (AZN) Exec to Replace Exiting Pharma Head 1/20/2017
5 Biotechs and the Drugs That May Put Them in Trump's Disfavor 1/20/2017
What You Need to Know About Decibel Therapeutics 1/20/2017
McKesson (MCK) to Pink Slip Some Employees in Wisconsin, Effective March 31 1/20/2017
Merck & Co. (MRK) Expands Discovery to New South San Francisco Facility in Heart of Bay Area and Looks to Hire 100 Employees 1/20/2017
Struggling MannKind (MNKD)'s New Strategy Includes Doubling Its Sales Force 1/19/2017
Calling All Scientists: 7 Things You Need to Know About Paid Biotech Internships 1/19/2017
Anonymous Short Trader Attacks Cellceutix (CTIX) Again 1/19/2017
What You Need to Know About Ideaya 1/19/2017
What You Need to Know About Morphic Therapeutic 1/19/2017
Sanofi (SNY) Exec Jumps Ship to Helm Merrimack (MACK) 1/19/2017
What Trump and His Potential Nominees Should Understand About the FDA 1/19/2017
Theranos Shuts Down Last Remaining Blood-Testing Lab After Another Failed Inspection 1/19/2017
Pfizer (PFE) CEO: What Trump Doesn't Understand About Pharma 1/19/2017
Massachusetts' CoLucid Pharma (CLCD) Surges on $960 Million Eli Lilly (LLY) Buyout Deal 1/19/2017
PAGXXV: Science, Crop Diseases and GMO Controversy 1/18/2017
What You Need to Know About Adicet Bio 1/18/2017
What You Need to Know About Codiak BioSciences 1/18/2017
2017 Could be The Breakout Year for These 5 Biotechs 1/18/2017
Embattled Theranos Forms New Advisory Board of Biotech Experts 1/18/2017
Battered Ophthotech (OPHT) Cuts 80% of Staff After Failed Clinical Trials 1/18/2017
ImmunoGen (IMGN) CEO Sees Potential in Company’s Lead ADC Product 1/18/2017
Meet the 27-Year Old CEO Who's Running Biotech Visikol 1/18/2017
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda (TKPYY) 1/18/2017
Why Bristol-Myers Squibb (BMY) Could be a Takeover Target Soon 1/18/2017



//-->